Novel Weekly Oral HIV Drug Safe in Early Trial of Healthy Volunteers

(MedPage Today) -- Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated promising safety in healthy adults without HIV. The findings were presented at the recent IDWeek annual...